URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Deepak Sahasrabudhe

Concepts (217)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Antigens, Neoplasm
5
1987
105
0.840
Why?
Polymorphism, Single Nucleotide
2
2010
87
0.710
Why?
Tissue Kallikreins
1
2010
11
0.690
Why?
Prostatic Neoplasms
3
2008
548
0.620
Why?
T-Lymphocytes, Cytotoxic
2
2001
130
0.530
Why?
HLA Antigens
1
2006
91
0.520
Why?
Receptors, Antigen, T-Cell
1
2006
68
0.520
Why?
Leukemia, Myeloid
1
2006
115
0.500
Why?
Colonic Neoplasms
2
1999
122
0.480
Why?
Antigens, Differentiation, Myelomonocytic
1
2003
24
0.430
Why?
Immune Tolerance
4
1986
145
0.430
Why?
Receptor, Epidermal Growth Factor
1
2003
90
0.400
Why?
Vascular Endothelial Growth Factor A
1
2003
192
0.380
Why?
Antigens, CD
1
2003
240
0.380
Why?
Organ Transplantation
1
2000
10
0.370
Why?
Lymphoproliferative Disorders
1
2000
30
0.360
Why?
Antigens, CD20
1
2000
26
0.360
Why?
T-Lymphocytes, Regulatory
3
1987
48
0.330
Why?
Sarcoma
2
2008
59
0.330
Why?
T-Lymphocytes
4
1986
546
0.320
Why?
Carcinoma, Renal Cell
2
1986
55
0.300
Why?
Kidney Neoplasms
2
1986
101
0.290
Why?
Middle Aged
12
1981
9461
0.270
Why?
Neoplasms, Second Primary
2
2008
124
0.270
Why?
Aged
12
1981
6986
0.270
Why?
Prognosis
4
1981
1030
0.260
Why?
Immunotherapy, Active
2
1990
6
0.260
Why?
Interferon-beta
1
1994
60
0.230
Why?
Interferon-alpha
1
1994
84
0.230
Why?
Neoadjuvant Therapy
2
2008
30
0.230
Why?
Neoplasms, Experimental
1
1994
146
0.230
Why?
Hypersensitivity, Delayed
2
1986
52
0.220
Why?
Humans
22
1981
35000
0.220
Why?
Genetic Markers
2
2010
127
0.220
Why?
Lung Neoplasms
3
1992
422
0.210
Why?
Male
13
1981
18870
0.210
Why?
Raynaud Disease
1
1992
7
0.210
Why?
Paraneoplastic Syndromes
1
1992
13
0.200
Why?
Genotype
2
2010
455
0.200
Why?
Spermatozoa
1
2012
32
0.200
Why?
Urinary Bladder Neoplasms
2
2005
170
0.190
Why?
Deferoxamine
1
1991
15
0.190
Why?
Androgen Antagonists
1
2012
64
0.190
Why?
Deoxycytidine
1
2011
26
0.190
Why?
Cisplatin
1
2011
93
0.180
Why?
Aged, 80 and over
4
2005
2423
0.180
Why?
Retrospective Studies
5
1990
2167
0.170
Why?
Radiosurgery
1
2011
73
0.170
Why?
Adult
8
1986
10906
0.170
Why?
Disease-Free Survival
1
2010
191
0.170
Why?
Alleles
1
2010
200
0.170
Why?
Breast Neoplasms
2
2004
660
0.160
Why?
Soft Tissue Neoplasms
1
2008
41
0.150
Why?
Amino Acid Sequence
3
2001
1198
0.150
Why?
Female
12
1986
19061
0.150
Why?
Recurrence
1
2010
656
0.150
Why?
Graft vs Host Disease
1
2008
92
0.150
Why?
Interferon Type I
1
1987
39
0.150
Why?
Cimetidine
1
1987
9
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2011
409
0.140
Why?
Mice, Inbred BALB C
4
1987
616
0.140
Why?
Bone Marrow Transplantation
1
2008
189
0.140
Why?
Skin Diseases
1
2008
120
0.140
Why?
Leukemia, Myeloid, Acute
1
2008
172
0.140
Why?
Tumor Cells, Cultured
3
1993
871
0.130
Why?
Urologic Neoplasms
1
2005
11
0.130
Why?
Quinolones
1
2005
24
0.120
Why?
Acute Disease
2
1983
570
0.120
Why?
Neoplasm Proteins
1
2006
164
0.120
Why?
Carcinoma, Transitional Cell
1
2005
52
0.120
Why?
Dinitrofluorobenzene
3
1987
7
0.120
Why?
Mice
6
1987
5900
0.120
Why?
Tumor Markers, Biological
1
2006
221
0.120
Why?
Molecular Sequence Data
2
2006
1993
0.120
Why?
Selective Estrogen Receptor Modulators
1
2004
9
0.110
Why?
CD8-Positive T-Lymphocytes
1
2006
223
0.110
Why?
Lymphocytes, Tumor-Infiltrating
1
2004
47
0.110
Why?
Cytotoxicity, Immunologic
2
1993
116
0.110
Why?
Cell Line, Tumor
1
2006
543
0.110
Why?
Acetates
1
2004
64
0.110
Why?
Hot Flashes
1
2004
28
0.110
Why?
Tamoxifen
1
2004
80
0.110
Why?
Cyclohexanecarboxylic Acids
1
2004
47
0.110
Why?
Neoplasm Metastasis
2
1986
219
0.110
Why?
Amines
1
2004
64
0.110
Why?
Angiogenesis Inducing Agents
1
2003
12
0.110
Why?
Enzyme Inhibitors
1
2005
396
0.110
Why?
gamma-Aminobutyric Acid
1
2004
90
0.110
Why?
Dendritic Cells
1
2004
110
0.100
Why?
Adenoviridae
1
2003
121
0.100
Why?
Colorectal Neoplasms
1
2004
138
0.100
Why?
Macrophages
1
2004
329
0.100
Why?
Genes, Lethal
1
2001
9
0.100
Why?
Melanoma
1
2003
133
0.100
Why?
Immunoglobulins
1
1981
71
0.100
Why?
Interferon-gamma
1
2003
340
0.090
Why?
Multivariate Analysis
1
2003
487
0.090
Why?
Animals
7
1987
15647
0.090
Why?
Multiple Myeloma
1
1981
73
0.090
Why?
Cell Division
2
1991
735
0.090
Why?
Herpesvirus 4, Human
1
2000
61
0.090
Why?
Intestine, Small
1
2000
110
0.090
Why?
Antibodies, Monoclonal, Murine-Derived
1
2000
124
0.090
Why?
Chemotherapy, Adjuvant
2
2008
85
0.080
Why?
Antineoplastic Agents
1
2005
598
0.080
Why?
Lymphoma, Large B-Cell, Diffuse
1
2000
72
0.080
Why?
Time Factors
3
1983
3047
0.080
Why?
Cancer Vaccines
1
1999
31
0.080
Why?
Recombinant Proteins
1
2001
706
0.080
Why?
Treatment Outcome
4
1999
2487
0.080
Why?
Rectal Neoplasms
1
1999
82
0.080
Why?
Interleukin-1
1
1999
204
0.080
Why?
Liver Transplantation
1
2000
246
0.070
Why?
Skin Tests
3
1987
35
0.070
Why?
Medical Oncology
1
1997
40
0.070
Why?
Fellowships and Scholarships
1
1997
48
0.070
Why?
Adenocarcinoma
2
1992
431
0.070
Why?
Cyclophosphamide
2
1986
169
0.070
Why?
Geriatrics
1
1997
76
0.070
Why?
Antibodies, Monoclonal
1
2000
725
0.070
Why?
Postoperative Complications
1
2000
706
0.070
Why?
Infant
1
2000
2102
0.060
Why?
Plasmacytoma
1
1994
9
0.060
Why?
Mice, Inbred DBA
1
1994
92
0.060
Why?
HLA-A2 Antigen
1
1993
8
0.060
Why?
Histocompatibility Antigens Class I
1
1994
92
0.060
Why?
Gene Products, gag
1
1993
17
0.060
Why?
Administration, Oral
2
2004
302
0.060
Why?
RNA, Messenger
1
2000
1791
0.060
Why?
DNA, Complementary
2
2001
261
0.060
Why?
Histocompatibility Antigens Class II
1
1994
187
0.050
Why?
Amputation
1
1992
22
0.050
Why?
Genetic Association Studies
1
2012
17
0.050
Why?
Child
1
2000
3897
0.050
Why?
Immunohistochemistry
2
2004
1024
0.050
Why?
tRNA Methyltransferases
1
2012
19
0.050
Why?
Treatment Failure
1
2012
125
0.050
Why?
Fingers
1
1992
71
0.050
Why?
Histiocytoma, Malignant Fibrous
1
2011
5
0.050
Why?
Ferric Compounds
1
1991
25
0.050
Why?
Sarcoma, Synovial
1
2011
7
0.050
Why?
Immunosuppression
1
1991
64
0.050
Why?
Leiomyosarcoma
1
2011
18
0.050
Why?
Liver Neoplasms
1
1992
149
0.050
Why?
Chlorides
1
1991
122
0.050
Why?
Radiotherapy Dosage
1
2011
185
0.040
Why?
Genetic Vectors
2
2001
328
0.040
Why?
Prospective Studies
2
2004
1606
0.040
Why?
Predictive Value of Tests
1
2012
579
0.040
Why?
Survivors
1
2011
112
0.040
Why?
Radiation Injuries
1
2011
123
0.040
Why?
Abdominal Neoplasms
1
2008
14
0.040
Why?
Biopsy, Fine-Needle
1
2008
21
0.040
Why?
Carcinoid Tumor
1
2008
26
0.040
Why?
Adenoma
1
2008
57
0.040
Why?
Pituitary Neoplasms
1
2008
64
0.040
Why?
Radiotherapy, Adjuvant
1
2008
72
0.040
Why?
Cohort Studies
1
2011
912
0.040
Why?
Cells, Cultured
1
1993
2367
0.040
Why?
Antigens
1
1987
101
0.040
Why?
Diphenhydramine
1
1987
9
0.040
Why?
Transplantation, Homologous
1
2008
261
0.040
Why?
Hybrid Cells
1
1987
26
0.040
Why?
Skin
1
1990
370
0.040
Why?
Immunization, Passive
1
1987
66
0.040
Why?
Antigens, Surface
1
1987
95
0.040
Why?
Immunotherapy
1
1986
88
0.030
Why?
Young Adult
1
2011
1013
0.030
Why?
Spleen
1
1987
338
0.030
Why?
Chronic Disease
1
2008
496
0.030
Why?
Receptor, erbB-2
1
2006
69
0.030
Why?
Exanthema
1
2005
11
0.030
Why?
Urothelium
1
2005
21
0.030
Why?
Intracellular Signaling Peptides and Proteins
1
2006
130
0.030
Why?
Diarrhea
1
2005
61
0.030
Why?
Remission Induction
1
2005
155
0.030
Why?
Neutropenia
1
2005
61
0.030
Why?
Eosinophils
1
2004
46
0.030
Why?
Risk Assessment
1
2008
808
0.030
Why?
Microsatellite Repeats
1
2004
43
0.030
Why?
Arabinofuranosyluracil
1
1983
2
0.030
Why?
Mast Cells
1
2004
45
0.030
Why?
Tomography, X-Ray Computed
1
2008
729
0.030
Why?
Cytarabine
1
1983
82
0.030
Why?
Uridine
1
1983
40
0.030
Why?
Injections, Intralesional
1
2003
12
0.030
Why?
Killer Cells, Natural
1
2004
122
0.030
Why?
beta 2-Microglobulin
1
2003
20
0.030
Why?
Leukemia
1
1983
152
0.030
Why?
Pilot Projects
1
2004
426
0.030
Why?
Survival Analysis
1
2004
575
0.020
Why?
Adolescent
1
2011
4513
0.020
Why?
Risk Factors
1
2008
2172
0.020
Why?
Ribosomal Proteins
1
2001
41
0.020
Why?
Vaccinia virus
1
2001
53
0.020
Why?
Interleukin-6
1
2003
314
0.020
Why?
Neoplasms
1
1987
701
0.020
Why?
Follow-Up Studies
1
2005
1757
0.020
Why?
Severity of Illness Index
1
2004
878
0.020
Why?
Hepatitis B Antibodies
1
1999
11
0.020
Why?
Lipid A
1
1999
9
0.020
Why?
Mycobacterium
1
1999
7
0.020
Why?
Adjuvants, Immunologic
1
1999
118
0.020
Why?
Base Sequence
1
2001
1681
0.020
Why?
Gene Expression Regulation
1
2001
848
0.020
Why?
Cell Fusion
1
1987
25
0.010
Why?
DNA, Neoplasm
1
1987
127
0.010
Why?
HeLa Cells
1
1987
291
0.010
Why?
Vaccination
1
1987
197
0.010
Why?
Flow Cytometry
1
1987
597
0.010
Why?
Radioimmunoassay
1
1983
111
0.010
Why?
Nucleoside Deaminases
1
1983
19
0.010
Why?
Infusions, Parenteral
1
1983
70
0.010
Why?
Chromatography, High Pressure Liquid
1
1983
206
0.010
Why?
Dose-Response Relationship, Drug
1
1983
1085
0.010
Why?
Kinetics
1
1983
1377
0.010
Why?
Models, Biological
1
1983
982
0.000
Why?

Visualizations


Sahasrabudhe's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department